Enzymit, the Israeli syn-bio production platform company, has announced the close of a $5 million seed round. Enzymit plans to accelerate its computational design platform to develop designer enzymes that can replace almost every chemical reaction used in modern fermentation methods, according to the company.
“Nature hasn’t supplied us with all of the enzymes humanity needs”
As the bioproduction industry grows, Enzymit has identified a lack of enzymes and organisms suitable for production as a challenge for the fermentation industry, as well as inefficient, unsustainable, and polluting chemical reactions. All of which makes the development of new production organisms challenging, claims Enzymit, while it bases its platform on enzymatic manufacturing, engineering ‘new-to-nature’ enzymes for bio-production.
Aiming to cut production costs and development times in the sector, Enzymit is developing a novel enzymatic process that can convert carbon from the air to novel bio-polymers cheaper than ever before. With this latest seed round investment, the company states it is well-positioned to take on the challenge and significantly impact this key market for future food production.
“While there is no dispute that humanity’s future relies on biomanufacturing, if we expect to maintain our standard of living in the face of increasing global pressures and growing population, nature hasn’t supplied us with all of the enzymes humanity needs. This is the bottleneck Enzymit aims to solve,” stated CEO and Co-Founder Dr. Gideon Lapidoth.
